Inhaled nitric oxide therapy in neonates and children: reaching a European consensus.

Autor:	Macrae, Duncan J., Field, David, Mercier, Jean-Christophe, Møller, Jens, Stiris, Tom, Biban, Paolo, Cornick, Paul, Goldman, Allan, Göthberg, Sylvia, Gustafsson, Lars E., Hammer, Jürg, Lönnqvist, Per-Arne, Sanchez-Luna, Manuel, Sedin, Gunnar, Subhedar, Nim, Møller, Jens, Göthberg, Sylvia, Hammer, Jürg, Lönnqvist, Per-Arne
Předmět:	PEDIATRIC research NITRIC oxide NITROGEN compounds NEONATAL intensive care INFANT health services CRITICAL care medicine THERAPEUTIC use of nitric oxide BRONCHODILATOR agents COMPARATIVE studies DOSE-effect relationship in pharmacology PREMATURE infants RESEARCH methodology MEDICAL cooperation PERSISTENT fetal circulation syndrome PULMONARY hypertension RESEARCH ADULT respiratory distress syndrome EVALUATION research TREATMENT effectiveness INHALATION administration PHARMACODYNAMICS THERAPEUTICS
Zdroj:	Intensive Care Medicine; Mar2004, Vol. 30 Issue 3, p372-380, 9p
Abstrakt:	Inhaled nitric oxide (iNO) was first used in neonatal practice in 1992 and has subsequently been used extensively in the management of neonates and children with cardiorespiratory failure. This paper assesses evidence for the use of iNO in this population as presented to a consensus meeting jointly organised by the European Society of Paediatric and Neonatal Intensive Care, the European Society of Paediatric Research and the European Society of Neonatology. Consensus Guidelines on the Use of iNO in Neonates and Children were produced following discussion of the evidence at the consensus meeting. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Full text from SpringerLink